Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are There Any Upcoming Cannabis-Based Pharmaceuticals for CRPS? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The search for new cannabis pharmaceuticals for CRPS is gathering pace, driven by increasing demand for regulated, targeted, and effective treatments. While medical cannabis is currently available in oils, capsules, and dried flower, pharmaceutical-grade formulations are being designed to deliver higher precision and consistency for Complex Regional Pain Syndrome patients. 

Unlike general cannabis products, these upcoming medicines are backed by rigorous testing, measured dosing, and formal approval processes. Their aim? To offer patients a safe, reliable alternative that fits within traditional medical frameworks. 

Book Consultation for Medical Cannabis

The Future of Prescription Cannabis 

Here’s what’s on the horizon in the world of cannabis-based CRPS medicine: 

  • Formulations under trial 
    Several biotech firms are developing clinical-grade cannabinoids designed for neuropathic and inflammatory pain. These prescription cannabis developments are progressing through early-stage human trials. 
  • Smarter delivery systems 
    Oral sprays, patches, and nano-formulated pills promise better absorption and reduced side effects. Many of these represent pharma innovation for CRPS with the goal of real-time symptom control. 
  • Standardised care options 
    By offering consistent cannabinoid profiles and physician-managed access, these products help bridge the gap between alternative and conventional medicine, especially in settings that demand clinical-grade cannabis. 

These advancements could transform how cannabis fits into mainstream CRPS care, providing new levels of precision and predictability. 

With science leading the way, new cannabis pharmaceuticals for CRPS may soon offer patients a stronger, safer toolkit for managing daily pain and recovery. 

Providers like LeafEase stay informed about emerging prescription options and can help guide patients as these treatments reach the market. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS)

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories